Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital

Journal of Clinical Pharmacology
Lee H GoldsteinMatitiyahu Berkovitch

Abstract

Adverse drug reactions (ADR) are underreported by doctors despite numerous efforts. We aimed to determine if establishing an "ADR reporting doctor's network" within a hospital would increase the quantity of ADRs reported by hospital doctors. One hundred hospital doctors joined the network. Email reminders were sent to network members during the 1 year study period, conveying information about ADRs reported, amusingly and pleasantly reminding them to report ADRs in minimal detail, by phone, email, text message or mail to the Clinical Pharmacology Unit, who would further complete the report. A total of 114 ADRs were reported during the study period in comparison to 48, 26, and 17 in the previous 3 years (2008, 2009, 2010, respectively). In the 3 years prior, doctors reported 41.7% of the reported ADRs whereas in the study period, doctors reported 74.3% of ADRs (P < .001), reflecting an 80% increase in doctors reports. Ninety seven percent of doctors' reports were of ADR network members. Thirty-four (34%) network members reported an ADR during the study period and 31 of the 34 reporters had never reported ADRs before becoming network members. Establishing an ADR network of doctors substantially increases ADR reporting amongst its ...Continue Reading

References

Sep 7, 2006·JAMA : the Journal of the American Medical Association·Adolfo FigueirasJuan Jesus Gestal-Otero
Jan 8, 2009·European Journal of Clinical Pharmacology·Marie-Louise JohanssonSusanna M Wallerstedt
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elena Lopez-GonzalezAdolfo Figueiras
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·C PedròsJ M Arnau
Jun 17, 2010·European Journal of Clinical Pharmacology·G CerezaJ M Arnau
Dec 16, 2010·Pharmacoepidemiology and Drug Safety·Jeffrey A LinderDavid W Bates
Apr 4, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Inês Ribeiro-VazRicardo Cruz-Correia
Jul 14, 2012·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Maria T HerdeiroAdolfo Figueiras

Citations

Jul 23, 2014·Journal of Paediatrics and Child Health·Sonya StaceyKaren Whitfield
Dec 30, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Elena Lopez-GonzalezGREPHEPI group
May 8, 2018·Journal of Clinical Pharmacology·Ar Kar AungLinda Velta Graudins
May 21, 2020·Pharmacoepidemiology and Drug Safety·Malahat KhaliliAli Akbar Haghdoost
Aug 14, 2020·PloS One·Miri Potlog ShchoryAmalia Levy
Sep 26, 2019·Frontiers in Pharmacology·Nirit KronenfeldIbrahim Abu-Kishk
Aug 11, 2020·Journal of Clinical Pharmacology·Emma M TillmanJennifer L Goldman

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.